Please check the individual session for location or broadcast availability.
Sagar Dhamne, MBBS, MD
James J. Dunn, PhD, D(ABMM)
Target Audience and Needs
Physicians, fellows, residents, students, and researchers need to receive regular updates on advances in the field of pathology, especially with regard to neoplasms and infectious diseases. The series aims to review molecular alterations in neoplastic lesions that may improve tumor classification and molecular markers that could serve as novel therapeutic targets. It also aims to explore host-parasite interactions and evidence-based laboratory guidelines to improve the diagnosis of infectious diseases and patient outcomes.
Educational methods may include lectures.
At the conclusion of the sessions, the participants should be able to:
- Describe the criteria and current recommendations developed by the international Society of Gynecologic Pathology to grade endocervical adenocarcinoma.
- Identify types of EGFR mutations in lung carcinoma and demonstrate their role as targets for new therapeutic agents.
- Diagnose ependymal tumors and recognize the differences in these tumors according to their location and molecular alterations.
- Explain how historical and longitudinal clinical laboratory test results can be used to develop targeted disease-state interventions for use in clinical workflows.
- Identify which investigative pathology tests are appropriate based on tumor type and site of origin.
- Distinguish whether a tumor specimen is the correct type and is an adequate size for testing.
- Evaluate advances in laboratory techniques used to detect bloodstream infections and the feasibility and effectiveness of these tests.
Participants may be asked to complete a session evaluation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.